This novel enhancer is easily integrated into existing workflows, and it produces 2-4x higher titers across a range of serotypes, cellular growth media formulations, and transfection platforms. RevIT™ AAV Enhancer can further drive down upstream manufacturing costs by permitting the use of lower levels of plasmid DNA while maintaining high-quality titers. Continual improvements in both upstream and downstream AAV manufacturing processes will allow the next generation of gene therapies to reach a broader audience.
RevIT AAV titer enhancer improves titer across serotypes when used with polymer-only transfection reagents.
RevIT AAV titer enhancer can be used with any media or cell line to increase titer.
VirusGEN® plus RevIT AAV titer enhancer outperformed polymer-only reagents.
RevIT AAV titer enhancer improves titer across serotypes when used with the VirusGEN® transfection platform.
All Configurations: Store at -20ºC, protected from exposure to light.
All Configurations: 6 months
All Configurations: For Research Use Only.
Animal Origin Statement
All Configurations: This product is animal origin free.
Technical Product Literature
RevIT™ AAV Enhancer QRP (PDF)
VirusGEN® AAV Kit with RevIT™ AAV Enhancer Protocol (PDF)
Quick Reference Protocol
VirusGEN® AAV Kit with RevIT™ AAV Enhancer QRP (PDF)
RevIT™ AAV Enhancer SDS (PDF)
VirusGEN® AAV Kit with RevIT™ AAV Enhancer SDS (PDF)
Virus Titer Reference Card: Methods to Measure Lentivirus and Adeno-associated Virus in Your Sample (PDF)
For a lot-specific Certificate of Analysis (COA) or Certificate of Origin (COO) containing a TSE/BSE Statement for this product, please contact email@example.com.